Singleton Mark Leonard 4

What Happened Mark Leonard Singleton, Senior Vice President and Chief Financial Officer of Bioventus, had 18,625 restricted stock units (RSUs) convert into shares on March 20, 2026. Of those shares, 8,091 were surrendered to satisfy tax withholding at $8.64 per share (total value withheld $69,906). The vesting/conversion (reported with code M) and the tax withholding (code F) resulted in a net issuance to Singleton of 10,534 shares. This was an RSU vesting and tax-withholding event, not an open-market purchase or opportunistic sale.

Key Details

• Transaction date: March 20, 2026; Form 4 filed March 24, 2026 (timely).
• Vesting/conversion: 18,625 RSUs converted to 18,625 shares (code M).
• Tax withholding: 8,091 shares withheld/disposed at $8.64/share, total ~$69,906 (code F).
• Net shares received by insider: 10,534 shares (18,625 − 8,091).
• Shares owned after transaction: not specified in the provided filing data.
• Footnotes: F1 – each RSU equals one share of Class A common stock; F2 – original grant was 74,500 RSUs that vest in four roughly equal annual installments beginning March 21, 2023.
• Nature of activity: award vesting with cashless tax withholding (routine compensation event).

Context This filing reflects routine RSU vesting for an executive and related share withholding to cover taxes. The conversion was not an open-market trade — withholding of shares to satisfy taxes is common and does not by itself indicate a market view. The filing appears timely (filed the second business day after the March 20 transaction).